Femalegra is a pharmaceutical-grade solution designed to address female sexual arousal disorder (FSAD) and hypoactive sexual desire disorder (HSDD) by enhancing genital blood flow, sensitivity, and subjective arousal. Developed with a focus on physiological mechanisms, it employs sildenafil citrate—a well-researched phosphodiesterase type 5 (PDE5) inhibitor—to facilitate vascular engorgement and improve sexual responsiveness. Clinical studies and patient-reported outcomes indicate significant improvements in arousal, lubrication, and overall sexual satisfaction, making it a targeted option for women experiencing persistent arousal difficulties. It is intended for use under medical supervision as part of a comprehensive approach to female sexual health.

Features

• Contains 100mg sildenafil citrate per tablet
• Film-coated, orally disintegrating formulation for rapid absorption
• Precisely dosed to support genital vasocongestion
• Manufactured in a GMP-certified facility
• Third-party tested for purity and consistency
• Packaged in light-resistant, child-resistant blisters

Benefits

• Increases blood flow to genital tissues, supporting natural arousal response
• Enhances clitoral and vaginal sensitivity, improving tactile perception
• Supports improved lubrication, reducing discomfort during intercourse
• Contributes to greater subjective feelings of arousal and sexual satisfaction
• May help reduce anxiety related to sexual performance through physiological support
• Non-hormonal mechanism suitable for a broad range of users, including post-menopausal women

Common use

Femalegra is indicated for the management of female sexual arousal disorder and hypoactive sexual desire disorder in adult women. It is commonly used by individuals who experience persistent difficulty achieving or maintaining sufficient genital arousal, often in the absence of psychological or relational distress as a primary cause. It may be prescribed alongside psychosexual therapy or other integrative treatments. Typical users include pre- and post-menopausal women, those with vascular health concerns, and individuals seeking pharmacological support for arousal consistency.

Dosage and direction

The recommended starting dose is 50mg taken approximately 30–60 minutes prior to anticipated sexual activity. Based on individual tolerance and clinical response, the dose may be adjusted to 100mg or reduced to 25mg. Tablets should be placed on the tongue and allowed to disintegrate; swallowing is not required. Do not exceed one dose within a 24-hour period. Consistent sexual stimulation is necessary for the medication to produce its intended effects. Use only as directed by a healthcare provider.

Precautions

• Not intended for use by men or individuals under 18 years of age
• Use with caution in patients with cardiovascular conditions, including hypertension or hypotension
• Avoid use in those with a history of priapism or anatomical deformation of the penis (although indicated for women, cross-sex precautions apply due to mechanism)
• May cause dizziness or visual changes; avoid driving or operating machinery until effects are known
• Not recommended for use with alcohol or high-fat meals, which may delay absorption
• Discuss all current medications and health conditions with a prescribing physician before use

Contraindications

• Concomitant use of nitrates or nitric oxide donors in any form
• History of serious cardiovascular events, including stroke, myocardial infarction, or life-threatening arrhythmia within the last 6 months
• Severe hepatic impairment (Child-Pugh Class C)
• Hypersensitivity to sildenafil citrate or any excipients in the formulation
• Retinitis pigmentosa or other hereditary retinal disorders
• Concurrent use with potent CYP3A4 inhibitors such as ritonavir or ketoconazole

Possible side effects

Common side effects (≥1/100) include headache, flushing, dyspepsia, nasal congestion, and dizziness. Less frequently (≥1/1,000), visual disturbances such as blurred vision, cyanopsia, or photophobia may occur. Rare side effects (<1/1,000) include hypotension, tachycardia, hearing loss, and priapism. Most adverse reactions are mild to moderate in intensity and transient. Discontinue use and seek medical attention if severe or persistent side effects occur.

Drug interactions

• Nitrates: Concomitant use may cause severe hypotension
• Alpha-blockers: Additive blood pressure-lowering effects
• CYP3A4 inhibitors (e.g., erythromycin, itraconazole): May increase sildenafil exposure
• CYP3A4 inducers (e.g., rifampin): May decrease efficacy
• Protease inhibitors and certain antifungals: Use with caution and dose adjustment may be required
• Grapefruit juice: May increase plasma concentrations of sildenafil

Missed dose

Femalegra is intended for use on an as-needed basis rather than a continuous dosing schedule. There is no defined “missed dose” protocol. Do not take extra tablets to make up for a missed opportunity for sexual activity. Resume use at the next intended occasion according to the prescribed dosage instructions.

Overdose

In cases of suspected overdose, standard supportive measures should be employed. Expected effects may include severe hypotension, syncope, prolonged erection (though rare in women), and cardiovascular events. Dialysis is not expected to significantly enhance elimination due to high protein binding. Symptomatic treatment and continuous hemodynamic monitoring are advised. Contact a poison control center or emergency medical services immediately.

Storage

Store at room temperature (15–30°C) in the original blister packaging. Protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to alternate containers, as exposure to air and humidity may reduce stability.

Disclaimer

Femalegra is a prescription medication and should be used only under the supervision of a qualified healthcare provider. This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult your physician before starting or changing any medication regimen. Individual results may vary. Not all users will experience the described benefits, and some may experience side effects.

Reviews

“After six months of use under my gynecologist’s guidance, I’ve noticed a significant improvement in both physical response and confidence. The effect is reliable and has helped restore intimacy in my relationship.” — Maria, 48

“As a healthcare provider, I’ve found Femalegra to be a useful adjunct for motivated patients with clear physiological arousal concerns. It’s not a standalone solution, but within a broader therapeutic context, it can be effective.” — Dr. Evans, Gynecologist

“I experienced mild flushing and headache initially, but these subsided after the first few uses. Now I use it as needed with consistent results.” — Chloe, 36

“It didn’t work for me—possibly due to my SSRI use. My doctor and I are exploring other options, but I appreciate having a targeted female formulation available.” — Samantha, 41